Top Midday Stories: US Q3 GDP Rises More Than Expected; Novo Nordisk Gets FDA Approval for Wegovy Pill

11:31 AM EST, 12/23/2025 (MT Newswires) -- All three major US stock indexes were up in late-morning trading Tuesday after delayed GDP data came in significantly above expectations.

US economic growth, measured by gross domestic product, rose by 4.3% in Q3 after a 3.8% increase in the previous quarter, faster than the 3.3% gain expected in a survey compiled by Bloomberg.

In company news, Novo Nordisk (NVO) said late Monday the US Food and Drug Administration approved its Wegovy pill for weight management and to reduce the risk of major adverse cardiovascular events. The company said it expects to launch the pill version of the drug in early January in the US. Novo Nordisk (NVO) shares were up 8.1% around midday.

ServiceNow (NOW) said Tuesday it has entered into an agreement to acquire cybersecurity firm Armis for $7.75 billion in cash. ServiceNow (NOW) said it plans to fund the acquisition through a combination of cash and debt. The deal is expected to close in H2 of 2026, the company said. ServiceNow (NOW) shares were down 2.6%.

US authorities are investigating the Singapore-based cloud computing company Megaspeed over alleged discrepancies between how many Nvidia (NVDA) chips it acquires and how many it uses in its data centers, Bloomberg reported Tuesday, citing people familiar with the matter. Nvidia (NVDA) shares were up 2.3%.

Price: 51.99, Change: +3.89, Percent Change: +8.09

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.